The need for phosphoproteomic approaches in psychiatric research.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Psychiatric Research

• Publication date

  2011-10-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/j.jpsychires.2011.04.007PMID 21616503
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Role of Energy Metabolism Dysfunction and Oxidative Stress in Schizophrenia Revealed by Proteomics

  2011cited by this paper
• Mass spectrometry mapping of epidermal growth factor receptor phosphorylation related to oncogenic mutations and tyrosine kinase inhibitor sensitivity.

  2011cited by this paper
• Different apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls

  2010cited by this paper
• Brain phosphoproteome obtained by a FASP-based method reveals plasma membrane protein topology.

  2010cited by this paper
• Multidimensional protein fractionation of blood proteins coupled to data-independent nanoLC-MS/MS analysis.

  2010cited by this paper
• Global proteomic profiling reveals altered proteomic signature in schizophrenia serum

  2010cited by this paper
• Profiling of mouse synaptosome proteome and phosphoproteome by IEF

  2010cited by this paper
• Proteome analysis of schizophrenia brain tissue

  2010cited by this paper
• Large-scale Proteomics Analysis of the Human Kinome

  2009cited by this paper
• Phosphoproteomics and cancer research

  2009cited by this paper
• Mediators of tau phosphorylation in the pathogenesis of Alzheimer’s disease

  2009cited by this paper
• Global and site-specific quantitative phosphoproteomics: principles and applications.

  2009cited by this paper
• Phosphoproteomics, oncogenic signaling and cancer research

  2008cited by this paper
• Novel Phosphorylation Sites in Tau from Alzheimer Brain Support a Role for Casein Kinase 1 in Disease Pathogenesis*

  2007cited by this paper
• Calcineurin (protein phosphatase 2B) is involved in the mechanisms of action of antidepressants.

  2007cited by this paper
• Tauopathies

  2007cited by this paper
• Regulation of Akt Signaling by D2 and D3 Dopamine Receptors In Vivo

  2007cited by this paper
• Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia

  2007cited by this paper
• Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease‐associated changes

  2006cited by this paper
• Phosphoproteomic Analysis of Neurotrophin Receptor TrkB Signaling Pathways in Mouse Brain

  2006cited by this paper
• Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions.

  2006cited by this paper
• Tau therapeutic strategies for the treatment of Alzheimer's disease.

  2006cited by this paper
• The effects of clozapine on the GSK‐3‐mediated signaling pathway

  2004cited by this paper
• Calcineurin regulation of neuronal plasticity.

  2003cited by this paper
• Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.

  2003cited by this paper
• Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit

  2003cited by this paper
• Toward the phosphoproteome

  2001cited by this paper
• Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex.

  2000cited by this paper
• Proline-directed and Non-proline-directed Phosphorylation of PHF-tau (*)

  1995cited by this paper
• Protein phosphorylation and neuronal function.

  1991cited by this paper
• Protein Phosphorylation and Neuronal Function

  1985cited by this paper

• LHPP, a risk factor for major depressive disorder, regulates stress-induced depression-like behaviors through its histidine phosphatase activity

  2022cites this paper
• Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry

  2017influential citation
• Psychiatric disorders biochemical pathways unraveled by human brain proteomics

  2017cites this paper
• Towards the Molecular Foundations of Glutamatergic-targeted Anti-depressants

  2016cites this paper
• Differential proteome and phosphoproteome may impact cell signaling in the corpus callosum of schizophrenia patients.

  2016cites this paper
• O proteoma do corpo caloso da esquizofrenia : The proteome of the corpus callosum in schizophrenia

  2016cites this paper
• Technological advances for deciphering the complexity of psychiatric disorders: merging proteomics with cell biology.

  2014cites this paper
• Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function

  2012cites this paper
• To label or not to label: Applications of quantitative proteomics in neuroscience research

  2012cites this paper
• Proteomic approaches to unravel the complexity of

  2012cites this paper
• Clinical use of phosphorylated proteins in blood serum analysed by immobilised metal ion affinity chromatography and mass spectrometry.

  2012cites this paper
• Protein phosphorylation patterns in serum from schizophrenia patients and healthy controls.

  2012cites this paper
• Differential phosphorylation of serum proteins reflecting inflammatory changes in schizophrenia patients

  2012cites this paper
• Proteomic approaches to unravel the complexity of schizophrenia

  2012cites this paper
• Proteomic technologies for biomarker studies in psychiatry: advances and needs.

  2011cites this paper